Literature DB >> 15550129

Self-detected cutaneous melanomas in Italian patients.

P Carli1, V De Giorgi, D Palli, A Maurichi, P Mulas, C Orlandi, G Imberti, I Stanganelli, P Soma, D Dioguardi, C Catricala, R Betti, S Paoli, U Bottoni, G Lo Scocco, M Scalvenzi, B Giannotti.   

Abstract

Self-detection of suspicious pigmented skin lesion combined with rapid referral to dermatologic centres is the key strategy in the fight against melanoma. The investigation of factors associated with pattern of detection of melanoma (self- vs. nonself-detection) may be useful to refine educational strategies for the future. We investigated the frequency of melanoma self-detection in a Mediterranean population at intermediate melanoma risk. A multicentric survey identified 816 consecutive cases of cutaneous melanoma in the period January to December 2001 in 11 Italian clinical centres belonging to the Italian Multidisciplinary Group on Melanoma. All patients filled a standardized questionnaire and were clinically examined by expert dermatologists. Self-detected melanomas were 40.6%, while the remaining lesions were detected by a dermatologist (18.5%), the family physician (15.2%), other specialists (5%), the spouse (12.5%), a friend or someone else (8.2%). Variables associated with self-detected melanomas were female sex, young age, absence of atypical nevi, knowledge of the ABCD rule, habit of performing skin self-examination. Self-detected melanomas did not differ from nonself-detected tumours in term of lesion thickness; however, patients with self-detected melanomas waited a longer period before having a diagnostic confirmation (patient's delay) (> 3 months: odds ratio, 3.89; 95% confidence interval, 2.74-5.53). In order to reduce the patients' delays, educational messages should adequately stress the need for a prompt referral to a physician once a suspicious pigmented lesion is self-detected.

Entities:  

Mesh:

Year:  2004        PMID: 15550129     DOI: 10.1111/j.1365-2230.2004.01628.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  The epidemiology, prevention, and detection of melanoma.

Authors:  Adam I Riker; Nicolas Zea; Tan Trinh
Journal:  Ochsner J       Date:  2010

2.  Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth.

Authors:  L J Titus; K Clough-Gorr; T A Mackenzie; A Perry; S K Spencer; J Weiss; S Abrahams-Gessel; M S Ernstoff
Journal:  Br J Dermatol       Date:  2012-10-05       Impact factor: 9.302

3.  Analysis of prognostic factors for melanoma patients.

Authors:  Andrė Lideikaitė; Julija Mozūraitienė; Simona Letautienė
Journal:  Acta Med Litu       Date:  2017

4.  Screening for malignant melanoma-a critical assessment in historical perspective.

Authors:  Wolfgang Weyers
Journal:  Dermatol Pract Concept       Date:  2018-04-30

5.  Inherited MC1R variants in patients with melanoma are associated with better survival in women.

Authors:  F E Lira; S Podlipnik; M Potrony; G Tell-Martí; N Calbet-Llopart; A Barreiro; C Carrera; J Malvehy; S Puig
Journal:  Br J Dermatol       Date:  2019-05-13       Impact factor: 9.302

6.  Patient-identified early clinical warning signs of nodular melanoma: a qualitative study.

Authors:  Susan M Swetter; Alan C Geller; Adina Coroiu; Chelsea Moran; Jessica A Davine; Kyla Brophy; Catherine Bergeron; Hensin Tsao; Annett Körner
Journal:  BMC Cancer       Date:  2021-04-07       Impact factor: 4.430

7.  Socioeconomic Determinants of Melanoma-Related Health Literacy and Attitudes Among College Students in China: A Population-Based Cross-Sectional Study.

Authors:  Tianhao Wu; Xianggui Wang; Shuang Zhao; Yi Xiao; Minxue Shen; Xi Han; Xiang Chen; Juan Su
Journal:  Front Public Health       Date:  2021-11-11

8.  Delay in cutaneous melanoma diagnosis: Sequence analyses from suspicion to diagnosis in 211 patients.

Authors:  Marcus H S B Xavier; Ana P Drummond-Lage; Cyntia Baeta; Lorena Rocha; Alessandra M Almeida; Alberto J A Wainstein
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.